The SFRP1 Inhibitor WAY-316606 Attenuates Osteoclastogenesis Through Dual Modulation of Canonical Wnt Signaling.
Ma Q, Wang S, Xie Z, Shen Y, Zheng B, Jiang C, Yuan P, Yu C, Li L, Zhao X, Chen J, Qin A, Fan S, Jie Z.
Ma Q, et al. Among authors: jiang c.
J Bone Miner Res. 2022 Jan;37(1):152-166. doi: 10.1002/jbmr.4435. Epub 2021 Sep 24.
J Bone Miner Res. 2022.
PMID: 34490916
Free article.